X

Vous n'êtes pas connecté

Maroc Maroc - WN.COM - Science - 25/Sep 14:24

Patient-Derived Dendritic Cell Immunotherapy Targets Difficult-to-Treat Cancers

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic complexity, invasive growth, and immune resistance. A new therapeutic approach against GBM involves engineered dendritic cells that mimic the immune response to viral intruders. Jay Hartenbach President and Chief Operating Officer Diakonos Oncology In this Innovation Spotlight, Jay Hartenbach, the president and chief operating officer of Diakonos Oncology, explains the company’s novel dendric cell cancer vaccine DOC1021, which has shown promising results in clinical trials. By “double-loading” patient-derived immune cells with patient-specific tumor...

Articles similaires

Sorry! Image not available at this time

Patient-Derived Dendritic Cell Immunotherapy Targets Difficult-to-Treat Cancers

wn.com - 25/Sep 14:24

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...

Genetic modification enhances "living drugs" for blood cancers

news.medical.net - 25/Sep 04:18

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping...

CELLFIE: Genetic boosters power up CAR-T cells

oncologynews.com.au - 25/Sep 23:48

CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in modern medicine....

Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers

oncologynews.com.au - 25/Sep 23:31

Researchers from Mass General Brigham, the Broad Institute of MIT and Harvard, USA, have identified genetic modifications that can improve the...

Engineered gut bacteria improves survival outcomes in colorectal cancer tumours

oncologynews.com.au - 03:27

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of...

New molecule offers a more targeted and potent immunotherapy

news.medical.net - 18/Sep 04:47

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and...

Cracking the Immune Code of Childhood Germ Cell Tumors

medindia.net - 20/Sep 20:10

Childhood germ cell tumors show unique immune patterns. New findings may lead to safer, smarter, and more personalized cancer treatments.

New study uncovers why dispersed glioblastoma cells are more dangerous

news.medical.net - 18/Sep 18:34

A new study, led by researchers at Sylvester Comprehensive Cancer Center part of the University of Miami Miller School of Medicine, captured details...

Sorry! Image not available at this time

Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight Report to 2030: U.S. Leads in Peptide Vaccine Development with Over 20 Active Projects - ResearchAndMarkets.com

wn.com - 15/Sep 17:35

DUBLIN--(BUSINESS WIRE)--The "Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight 2030" report has been...

The Single Cell Boron Secret for Precision Cancer Therapy

medindia.net - 13/Sep 13:54

Researchers bmeasured boron in individual live cells of medlinkhead and neck cancer/medlink, contributing to a better drug design and precision

Les derniers communiqués